News & Articles

Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development

Learn how CancerTools.org is rewriting how cancer research tools move from lab benches to scientists around the world, and how the profits are put straight back into fighting cancer

Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling

Hear how the Ocular Tissue Engineering Laboratory is addressing retinal cell culture challenges via an automated stem cell robot platform

Registration now open

Partnership follows successful scale-up of CHO Edge System by LOTTE BIOLOGICS

Defined stem cell media offers easy transition to clinical manufacturing

Charles River to provide master cell banking and NGS testing services for cord blood derived allogeneic CAR-T cells

The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level

New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy

High-throughput platform accelerates drug discovery by reducing the number of manual steps by up to 90%

Successes across the de-extinction pipeline signal that the thylacine project is on track as Colossal continues its global effort to fight the extinction crisis

This guest editorial explores how advances in single-cell technologies to reveal novel insights into hematopoietic development

Discovery advances research into how diabetes impacts and damages blood vessels

Cytovance and Celltheon partner to provide an integrated solution for customers seeking to outsource cell line development through to cGMP manufacturing of mammalian-expressed products

Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice

AMSBIO launches new Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line

Dr. Priya Chockalingam discusses the complexities of cell and gene therapies and how single-cell multimodal analysis can efficiently characterize gene-edited products

The vaccine quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor

Learn how Thermo Fisher Scientific’s Cytomat™ 2 Selector Automated Shaking Incubator can enable biologics to reach the market faster